Trial Site Detail

 

Drug:
LOXO-101
Trial:
Study of LOXO-101 in Subjects With NTRK Fusion Positive Solid Tumors
Conditions: Sarcoma
Trial Status:
Active, not recruiting

 

Institut Bergonie

229 Cours Argonne     
Bordeaux , Gironde 33076
France

 

Principal Investigator:
Contact:
Antoine Italiano
Activation Status of this Site:
Active
Notes about this Site:
Institut Bergonie Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.